MoneyWorks4Me

Tatva Chintan Pharma - Quaterly Results

17 Jan 2022 Evaluate
The sales moved up 33.38% to Rs. 1015.92 millions for the December 2021 quarter as compared to Rs. 761.67 millions during the year-ago period.Net profit stood at Rs. 224.28  millions  compared to Rs. 199.75 millions in the corresponding previous quarter,high by 12.28%.OP of the company witnessed a marginal growth to 278.39 millions from 240.75 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202112 202012 % Var
Sales 1015.92 761.67 33.38 1015.92 761.67 33.38 1015.92 761.67 33.38
Other Income 50.81 7.58 570.32 50.81 7.58 570.32 50.81 7.58 570.32
PBIDT 278.39 240.75 15.63 278.39 240.75 15.63 278.39 240.75 15.63
Interest 9.88 11.09 -10.91 9.88 11.09 -10.91 9.88 11.09 -10.91
PBDT 268.51 229.66 16.92 268.51 229.66 16.92 268.51 229.66 16.92
Depreciation 20.76 15.89 30.65 20.76 15.89 30.65 20.76 15.89 30.65
PBT 247.75 213.77 15.90 247.75 213.77 15.90 247.75 213.77 15.90
TAX 23.47 14.02 67.40 23.47 14.02 67.40 23.47 14.02 67.40
Deferred Tax -24.51 -3.24 656.48 -24.51 -3.24 656.48 -24.51 -3.24 656.48
PAT 224.28 199.75 12.28 224.28 199.75 12.28 224.28 199.75 12.28
Equity 221.65 80.35 175.86 221.65 80.35 175.86 221.65 80.35 175.86
PBIDTM(%) 27.40 31.61 -13.30 27.40 31.61 -13.30 27.40 31.61 -13.30
Peers
Company Name CMP
Godrej Industries 1063.65
SRF 2469.60
BASF India 3477.55
Pidilite Inds. 1477.00
Tata Chemicals 621.25
View more..